PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma

Yoshihiro Otani, Joji Ishida, Kazuhiko Kurozumi, Tetsuo Oka, Toshihiko Shimizu, Yusuke Tomita, Yasuhiko Hattori, Atsuhito Uneda, Yuji Matsumoto, Hiroyuki Michiue, Shuta Tomida, Takehiro Matsubara, Tomotsugu Ichikawa, Isao Date

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Despite therapeutic advances, glioblastoma represents a lethal brain tumor. Recently, research to identify prognostic markers for glioblastoma has intensified. Our previous study demonstrated that median progression-free survival (PFS) and overall survival (OS) of patients with high cysteine-rich protein 61 (CCN1) expression was significantly shorter than that of patients with low CCN1 expression. To understand the molecular mechanisms that regulate CCN1 expression, we examined 147 tumour samples from 80 patients with glioblastoma and 67 patients with lower grade glioma. Next-generation and Sanger sequencing showed that PIK3R1Met326Ile was more frequent in the CCN1 high expression group (10/37 cases, 27.0%) than the CCN1 low expression group (3/38 cases, 7.9%) in glioblastoma. This mutation was also detected in corresponding blood samples. In multivariate analysis, high CCN1 expression and PIK3R1Met326Ile in glioblastoma patients were prognostic factors for OS [HR = 2.488 (1.298-4.769), p = 0.006] and [HR = 2.089 (1.020-4.277), p = 0.0439], respectively. Thus, the PIK3R1Met326Ile germline appears to be correlated with CCN1 expression and poor prognosis in glioblastoma.

Original languageEnglish
Article number7391
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Cysteine-Rich Protein 61
Germ-Line Mutation
Glioblastoma
Survival
Brain Neoplasms
Glioma
Disease-Free Survival
Multivariate Analysis
Mutation

ASJC Scopus subject areas

  • General

Cite this

PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma. / Otani, Yoshihiro; Ishida, Joji; Kurozumi, Kazuhiko; Oka, Tetsuo; Shimizu, Toshihiko; Tomita, Yusuke; Hattori, Yasuhiko; Uneda, Atsuhito; Matsumoto, Yuji; Michiue, Hiroyuki; Tomida, Shuta; Matsubara, Takehiro; Ichikawa, Tomotsugu; Date, Isao.

In: Scientific Reports, Vol. 7, No. 1, 7391, 01.12.2017.

Research output: Contribution to journalArticle

Otani, Yoshihiro ; Ishida, Joji ; Kurozumi, Kazuhiko ; Oka, Tetsuo ; Shimizu, Toshihiko ; Tomita, Yusuke ; Hattori, Yasuhiko ; Uneda, Atsuhito ; Matsumoto, Yuji ; Michiue, Hiroyuki ; Tomida, Shuta ; Matsubara, Takehiro ; Ichikawa, Tomotsugu ; Date, Isao. / PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{d645a28e99fb4049999400f22b472fca,
title = "PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma",
abstract = "Despite therapeutic advances, glioblastoma represents a lethal brain tumor. Recently, research to identify prognostic markers for glioblastoma has intensified. Our previous study demonstrated that median progression-free survival (PFS) and overall survival (OS) of patients with high cysteine-rich protein 61 (CCN1) expression was significantly shorter than that of patients with low CCN1 expression. To understand the molecular mechanisms that regulate CCN1 expression, we examined 147 tumour samples from 80 patients with glioblastoma and 67 patients with lower grade glioma. Next-generation and Sanger sequencing showed that PIK3R1Met326Ile was more frequent in the CCN1 high expression group (10/37 cases, 27.0{\%}) than the CCN1 low expression group (3/38 cases, 7.9{\%}) in glioblastoma. This mutation was also detected in corresponding blood samples. In multivariate analysis, high CCN1 expression and PIK3R1Met326Ile in glioblastoma patients were prognostic factors for OS [HR = 2.488 (1.298-4.769), p = 0.006] and [HR = 2.089 (1.020-4.277), p = 0.0439], respectively. Thus, the PIK3R1Met326Ile germline appears to be correlated with CCN1 expression and poor prognosis in glioblastoma.",
author = "Yoshihiro Otani and Joji Ishida and Kazuhiko Kurozumi and Tetsuo Oka and Toshihiko Shimizu and Yusuke Tomita and Yasuhiko Hattori and Atsuhito Uneda and Yuji Matsumoto and Hiroyuki Michiue and Shuta Tomida and Takehiro Matsubara and Tomotsugu Ichikawa and Isao Date",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-07745-0",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma

AU - Otani, Yoshihiro

AU - Ishida, Joji

AU - Kurozumi, Kazuhiko

AU - Oka, Tetsuo

AU - Shimizu, Toshihiko

AU - Tomita, Yusuke

AU - Hattori, Yasuhiko

AU - Uneda, Atsuhito

AU - Matsumoto, Yuji

AU - Michiue, Hiroyuki

AU - Tomida, Shuta

AU - Matsubara, Takehiro

AU - Ichikawa, Tomotsugu

AU - Date, Isao

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Despite therapeutic advances, glioblastoma represents a lethal brain tumor. Recently, research to identify prognostic markers for glioblastoma has intensified. Our previous study demonstrated that median progression-free survival (PFS) and overall survival (OS) of patients with high cysteine-rich protein 61 (CCN1) expression was significantly shorter than that of patients with low CCN1 expression. To understand the molecular mechanisms that regulate CCN1 expression, we examined 147 tumour samples from 80 patients with glioblastoma and 67 patients with lower grade glioma. Next-generation and Sanger sequencing showed that PIK3R1Met326Ile was more frequent in the CCN1 high expression group (10/37 cases, 27.0%) than the CCN1 low expression group (3/38 cases, 7.9%) in glioblastoma. This mutation was also detected in corresponding blood samples. In multivariate analysis, high CCN1 expression and PIK3R1Met326Ile in glioblastoma patients were prognostic factors for OS [HR = 2.488 (1.298-4.769), p = 0.006] and [HR = 2.089 (1.020-4.277), p = 0.0439], respectively. Thus, the PIK3R1Met326Ile germline appears to be correlated with CCN1 expression and poor prognosis in glioblastoma.

AB - Despite therapeutic advances, glioblastoma represents a lethal brain tumor. Recently, research to identify prognostic markers for glioblastoma has intensified. Our previous study demonstrated that median progression-free survival (PFS) and overall survival (OS) of patients with high cysteine-rich protein 61 (CCN1) expression was significantly shorter than that of patients with low CCN1 expression. To understand the molecular mechanisms that regulate CCN1 expression, we examined 147 tumour samples from 80 patients with glioblastoma and 67 patients with lower grade glioma. Next-generation and Sanger sequencing showed that PIK3R1Met326Ile was more frequent in the CCN1 high expression group (10/37 cases, 27.0%) than the CCN1 low expression group (3/38 cases, 7.9%) in glioblastoma. This mutation was also detected in corresponding blood samples. In multivariate analysis, high CCN1 expression and PIK3R1Met326Ile in glioblastoma patients were prognostic factors for OS [HR = 2.488 (1.298-4.769), p = 0.006] and [HR = 2.089 (1.020-4.277), p = 0.0439], respectively. Thus, the PIK3R1Met326Ile germline appears to be correlated with CCN1 expression and poor prognosis in glioblastoma.

UR - http://www.scopus.com/inward/record.url?scp=85026900616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026900616&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-07745-0

DO - 10.1038/s41598-017-07745-0

M3 - Article

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 7391

ER -